These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16113749)

  • 1. Chromogenic methods in coagulation diagnostics.
    Rosén S
    Hamostaseologie; 2005 Aug; 25(3):259-66. PubMed ID: 16113749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Round table on the use of chromogenic substrates in hemostasiologic diagnosis].
    Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):189-200. PubMed ID: 6177604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chromogenic substrate as antidote against the thrombin inhibitor Melagatran?].
    Bodendiek I; Lentz S; Seeger M; Bruhn HD
    Hamostaseologie; 2003 May; 23(2):97-8. PubMed ID: 12736706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 6. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays.
    Beeck H; Nagel D; Pindur G; Scharrer I; Preiss A; Seiler D; Hellstern P
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):127-35. PubMed ID: 10759005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
    Aiach M; Léon M; Michaud A; Capron L
    Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
    [No Abstract]   [Full Text] [Related]  

  • 14. Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many.
    Girolami A; Vettore S
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):484-5. PubMed ID: 19675419
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte procoagulant activity: development of a microtitre plate chromogenic assay.
    Baker P; Joshi M; Luddington R
    Br J Biomed Sci; 1994 Dec; 51(4):328-31. PubMed ID: 7756938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
    Duncan A; Bowie EJ; Owen CA; Fass DN
    Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test systems with synthetic peptide substrates in haemostaseology.
    Witt I
    Eur J Clin Chem Clin Biochem; 1991 Jun; 29(6):355-74. PubMed ID: 1912084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin generation by heparin and LMW heparins: a comparison of chromogenic and clotting methods.
    Houbouyan L; Padilla A; Gray E; Longstaff C; Barrowcliffe TW
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):24-30. PubMed ID: 8845459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.